UBS Group AG - THRESHOLD PHARMACEUTICAL INC ownership

THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 72 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q1 2016. The put-call ratio across all filers is 3.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of THRESHOLD PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2017$1,000
-92.9%
2,000
-92.1%
0.00%
Q1 2017$14,000
-17.6%
25,357
-31.8%
0.00%
Q4 2016$17,000
+30.8%
37,162
+98.6%
0.00%
Q3 2016$13,000
+62.5%
18,714
+48.7%
0.00%
Q2 2016$8,000
+700.0%
12,585
+494.8%
0.00%
Q1 2016$1,0000.0%2,116
+89.6%
0.00%
Q4 2015$1,000
-95.2%
1,116
-78.2%
0.00%
Q3 2015$21,0000.0%5,1160.0%0.00%
Q2 2015$21,000
+133.3%
5,116
+141.8%
0.00%
Q1 2015$9,000
-55.0%
2,116
-67.0%
0.00%
Q4 2014$20,0006,4170.00%
Other shareholders
THRESHOLD PHARMACEUTICAL INC shareholders Q1 2016
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,333,490$847,0000.43%
Cormorant Asset Management, LP 1,012,255$643,0000.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,583,160$1,641,0000.06%
Alpine Global Management, LLC 85,791$55,0000.02%
Rhenman & Partners Asset Management AB 201,537$128,0000.02%
FRANKLIN STREET ADVISORS INC /NC 70,000$44,0000.01%
LMR Partners LLP 80,123$51,0000.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,500,000$2,224,0000.01%
First Eagle Investment Management, LLC 3,199,433$2,033,0000.01%
OXFORD ASSET MANAGEMENT LLP 202,522$129,0000.00%
View complete list of THRESHOLD PHARMACEUTICAL INC shareholders